Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05774704 · ClinicalTrials.gov registry record · Phase 1
Curcumin and Retinal Study
A Phase 1 study of Gut Microbiome and Safety, sponsored by Texas Tech University Health Sciences Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05774704 is a Phase 1 study of Gut Microbiome and Safety that is actively recruiting participants, run by Texas Tech University Health Sciences Center. The registered enrollment target is 60 participants, below the 265-participant average among 22 other Gut Microbiome trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05774704, a Phase 1 study of Gut Microbiome and Safety, is actively recruiting participants, sponsored by Texas Tech University Health Sciences Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.
Conditions Studied
Interventions
- DRUG Low curcumin group
- DRUG High curcumin group
Study Locations (1)
Texas
- Texas Tech University Health Sciences Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-08-21 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05774704
The ClinicalTrials.gov registry entry for NCT05774704 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 265-participant average among 22 other Gut Microbiome trials with a reported enrollment target (77% lower). The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gut Microbiome appearing as the primary indexed condition, and to 2 interventions - of which Low curcumin group is the first listed.
NCT05774704 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05774704 about?
NCT05774704 is a clinical study titled "Curcumin and Retinal Study". To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.
What is the current status of trial NCT05774704?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2023-08-21. Estimated completion is 2026-12-31.
What conditions does trial NCT05774704 study?
This clinical trial studies the following conditions: Gut Microbiome, Safety, Bioavailability.
What interventions are being tested in trial NCT05774704?
The interventions under investigation include: Low curcumin group (DRUG), High curcumin group (DRUG).
Who is sponsoring clinical trial NCT05774704?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05774704 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut Microbiome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Flourish: Exploring the Early Infant Gut Microbiome
RECRUITING · NA
-
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
RECRUITING · NA
-
Enhanced Nutritional Optimization in LVAD Trial
RECRUITING · NA
-
Feasibility and Potential Efficacy of Herbs and Spices for Improving Dietary Quality in College Students: A Pilot Study
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.